Comparison of graft versus host disease with three different alemtuzumab schedules in unrelated donor fludarabine and melphalan allografts

Alemtuzumab conditioning is highly effective at reducing the incidence of acute and chronic graft versus host disease (GVHD) in reduced intensity fludarabine and melphalan transplantation with ciclosporin monotherapy. Less frequent and lower dose scheduling may be used with sibling donors but an opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Kile, Pearce, Kim, Sellar, Rob S, Jardine, Laura, Nicolson, Phillip LR, Nagra, Sandeep, Bigley, Venetia, Jackson, Graham, Dickinson, Anne M, Thomson, Kirsty, Mackinnon, Stephen, Craddock, Charles, Peggs, Karl S, Collin, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588535/
https://www.ncbi.nlm.nih.gov/pubmed/28212937
http://dx.doi.org/10.1016/j.bbmt.2017.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588535/
https://www.ncbi.nlm.nih.gov/pubmed/28212937
http://dx.doi.org/10.1016/j.bbmt.2017.02.007

Ejemplares similares